BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15081036)

  • 1. Design, synthesis and cytotoxicity of 7-deoxy aryl discodermolide analogues.
    Burlingame MA; Shaw SJ; Sundermann KF; Zhang D; Petryka J; Mendoza E; Liu F; Myles DC; LaMarche MJ; Hirose T; Scott Freeze B; Smith AB
    Bioorg Med Chem Lett; 2004 May; 14(9):2335-8. PubMed ID: 15081036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and evaluation of carbamate-substituted analogues of (+)-discodermolide.
    Smith AB; Freeze BS; Lamarche MJ; Hirose T; Brouard I; Rucker PV; Xian M; Sundermann KF; Shaw SJ; Burlingame MA; Horwitz SB; Myles DC
    Org Lett; 2005 Jan; 7(2):311-4. PubMed ID: 15646985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic analogues of the microtubule-stabilizing agent (+)-discodermolide: preparation and biological activity.
    Gunasekera SP; Mickel SJ; Daeffler R; Niederer D; Wright AE; Linley P; Pitts T
    J Nat Prod; 2004 May; 67(5):749-56. PubMed ID: 15165132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward understanding how the lactone moiety of discodermolide affects activity.
    Shaw SJ; Sundermann KF; Burlingame MA; Myles DC; Freeze BS; Xian M; Brouard I; Smith AB
    J Am Chem Soc; 2005 May; 127(18):6532-3. PubMed ID: 15869264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of simplified analogues of (+)-discodermolide. Additional insights on the importance of the diene, the C7 hydroxyl, and the lactone.
    Smith AB; Xian M
    Org Lett; 2005 Nov; 7(23):5229-32. PubMed ID: 16268545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total synthesis of the potent microtubule-stabilizing agent (+)-discodermolide.
    Harried SS; Lee CP; Yang G; Lee TI; Myles DC
    J Org Chem; 2003 Aug; 68(17):6646-60. PubMed ID: 12919029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, total synthesis, and evaluation of C13-C14 cyclopropane analogues of (+)-discodermolide.
    Smith AB; Xian M; Liu F
    Org Lett; 2005 Oct; 7(21):4613-6. PubMed ID: 16209492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of practical syntheses of the marine anticancer agents discodermolide and dictyostatin.
    Florence GJ; Gardner NM; Paterson I
    Nat Prod Rep; 2008 Apr; 25(2):342-75. PubMed ID: 18389141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total synthesis of a potent hybrid of the anticancer natural products dictyostatin and discodermolide.
    Paterson I; Naylor GJ; Wright AE
    Chem Commun (Camb); 2008 Oct; (38):4628-30. PubMed ID: 18815706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discodermolide/Dictyostatin hybrids: synthesis and biological evaluation.
    Shin Y; Choy N; Turner TR; Balachandran R; Madiraju C; Day BW; Curran DP
    Org Lett; 2002 Dec; 4(25):4443-6. PubMed ID: 12465908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coumarin-derived discodermolide analogues possessing equivalent antiproliferative activity to the natural product--a further simplification of the lactone region.
    Shaw SJ; Menzella HG; Myles DC; Xian M; Smith AB
    Org Biomol Chem; 2007 Sep; 5(17):2753-5. PubMed ID: 17700839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conception, synthesis, and biological evaluation of original discodermolide analogues.
    de Lemos E; Agouridas E; Sorin G; Guerreiro A; Commerçon A; Pancrazi A; Betzer JF; Lannou MI; Ardisson J
    Chemistry; 2011 Aug; 17(36):10123-34. PubMed ID: 21793059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A second-generation total synthesis of (+)-discodermolide: the development of a practical route using solely substrate-based stereocontrol.
    Paterson I; Delgado O; Florence GJ; Lyothier I; O'Brien M; Scott JP; Sereinig N
    J Org Chem; 2005 Jan; 70(1):150-60. PubMed ID: 15624917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total synthesis of a library of designed hybrids of the microtubule-stabilising anticancer agents taxol, discodermolide and dictyostatin.
    Paterson I; Naylor GJ; Fujita T; Guzmán E; Wright AE
    Chem Commun (Camb); 2010 Jan; 46(2):261-3. PubMed ID: 20024345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward a commercial synthesis of (+)-discodermolide.
    Mickel SJ
    Curr Opin Drug Discov Devel; 2004 Nov; 7(6):869-81. PubMed ID: 15595446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semisynthetic analogues of the microtubule-stabilizing agent discodermolide: preparation and biological activity.
    Gunasekera SP; Longley RE; Isbrucker RA
    J Nat Prod; 2002 Dec; 65(12):1830-7. PubMed ID: 12502323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structure activity relationship of discodermolide analogues.
    Shaw SJ
    Mini Rev Med Chem; 2008 Mar; 8(3):276-84. PubMed ID: 18336347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discodermolide analogues as the chemical component of combination bacteriolytic therapy.
    Smith AB; Freeze BS; LaMarche MJ; Sager J; Kinzler KW; Vogelstein B
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3623-6. PubMed ID: 15979874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and evaluation of analogues of (+)-14-normethyldiscodermolide.
    Smith AB; Freeze BS; Lamarche MJ; Hirose T; Brouard I; Xian M; Sundermann KF; Shaw SJ; Burlingame MA; Horwitz SB; Myles DC
    Org Lett; 2005 Jan; 7(2):315-8. PubMed ID: 15646986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (+)-discodermolide: a marine natural product against cancer.
    De Souza MV
    ScientificWorldJournal; 2004 Jun; 4():415-36. PubMed ID: 15243683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.